Pfizer Announces New $10 Billion Share Repurchase Program

Pfizer Inc., the world’s largest drugmaker, authorized a new share buyback program for as much as $10 billion as Lipitor lost about 15 percent of its market in the first week the cholesterol pill faced generic competition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.